Skip to main content

Table 1 Demographics of patients with COVID-19

From: Impact of COVID-19 on digestive system: prevalence, clinical characteristics, outcome, and relation to the severity of COVID-19

Characteristics

All patients

N=300

GI group

N=104

Non- GI group

N=196

P value

Age, mean ± SD

56.95 ± 14.3

54.0± 14.4

58.5± 14.1

0.009*

Gender, n (%)

0.4

 Male

165

(55)

54

(51.9)

111

(56.6)

 

 Female

135

(45)

50

(48.1)

85

(43.4)

Comorbidities, n (%)

 Diabetes mellitus

109

(36.3)

33

(31.7)

76

(38.8)

0.22

 Hypertension

137

(45.7)

42

(40.4)

95

(48.5)

0.12

 Cardiovascular disease

61

(20.3)

16

(15.4)

45

(23)

0.12

 Pulmonary disorders

24

(8)

10

(9.6)

14

(7.1)

0.45

 Neuropsychiatric disorders

23

(7.7)

6

(5.8)

17

(8.7)

0.37

 Renal disease

20

(6.7)

7

(6.7)

13

(6.6)

0.97

 Endocrinal disorders

9

(3)

3

(2.9)

6

(3.1)

0.62

 Hematological disorders

3

(1)

1

(1)

2

(1)

0.72

 Rheumatological & immunological disorders

16

(5.3)

6

(5.8)

10

(5.1)

0.81

 DVT

4

(1.3)

1

(1)

3

(1.5)

0.57

 Chronic liver disease

16

(5.3)

3

(2.9)

13

(6.6)

0.17

 Malignancy

20

(6.7)

8

(7.7)

12

(6.1)

0.6

Severity, n (%)

0.32

 Moderate

294

(98.0)

103

(99.0)

191

(97.4)

 

 Severe

6

(2.0)

1

(1.0)

5

(2.6)

  1. *Significant